IndiaDescription
Founded in 1998, it began by making quinine derivatives and today declares more than forty-five active ingredients. It runs two plants at Vapi, Gujarat, totalling 30,000 square metres, with a head office at Vile Parle, Mumbai. Its portfolio covers quinine and derivatives, hyoscine butylbromide, artemisinin derivatives, lumefantrine, aciclovir, mecobalamin and digoxin.